Process for cognate nucleotide detection in a nucleic acid sequencing workflow

US12344890B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12344890-B2
Application numberUS-202117190894-A
CountryUS
Kind codeB2
Filing dateMar 3, 2021
Priority dateJan 20, 2017
Publication dateJul 1, 2025
Grant dateJul 1, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Method and composition for identifying cognate nucleotides in a Sequencing By Binding™ procedure, wherein one or more labeled nucleotides are detected in ternary complexes but never incorporated. Labeled nucleotides can be incorporable nucleotides that contact preformed blocked primed template nucleic acids. Alternatively, labeled nucleotides are labeled non-incorporable nucleotides. Labeled nucleotides, including labeled non-incorporable nucleotides, can be detected in ternary complexes in the same reaction mixture that incorporates a reversible terminator nucleotide to create a blocked primed template nucleic acid. Detection of ternary complexes can take place in the presence of a catalytic metal ion.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of identifying cognate nucleotides for each of a plurality of nucleic acid features, each feature comprising a primed template nucleic acid molecule, said method comprising the steps of: (a) preparing first stabilized ternary complexes at each of the plurality of nucleic acid features, each stabilized ternary complex comprising the primed template nucleic acid molecule at its respective nucleic acid feature, a reversible terminator nucleotide, and a polymerase; (b) contacting the first stabilized ternary complexes from step (a) with a reagent comprising a catalytic metal ion, at least one distinguishably labeled incorporable nucleotide, and a polymerase, to produce a reaction mixture, whereby the reversible terminator nucleotide incorporates into the primed template nucleic acid molecule to produce a blocked primed template nucleic acid molecule at each of the plurality of nucleic acid features, and whereby there forms at each of the plurality of nucleic acid features a second stabilized ternary complex comprising the blocked primed template nucleic acid molecule and one of the distinguishably labeled incorporable nucleotides; and (c) identifying cognate nucleotides for the primed template nucleic acid molecules at each of the plurality of nucleic acid features by detecting, in the reaction mixture, a label joined to the distinguishably labeled incorporable nucleotide of the second stabilized ternary complex. 2. The method of claim 1 , wherein the polymerase of step (b) is the same type of polymerase as in step (a). 3. The method of claim 1 , wherein the blocked primed template nucleic acid molecule of step (b) comprises a reversible terminator moiety at its 3′ terminus, and wherein the method further comprises the step of cleaving the reversible terminator moiety from the blocked primed template nucleic acid molecule to produce a 3′ terminus available for polymerization. 4. The method of claim 1 , wherein the catalytic metal ion in the second reaction mixture is selected from the group consisting of Mg 2+ ion and Mn 2+ ion. 5. The method of claim 1 , wherein the blocked primed template nucleic acid molecule of step (b) is immobilized to a solid support and wherein the solid support is contained within a flow cell. 6. The method of claim 5 , wherein each of the plurality of nucleic acid features is contained within the flow cell. 7. The method of claim 1 , wherein the label on the distinguishably labeled incorporable nucleotides is a distinguishable fluorescent label. 8. The method of claim 7 , wherein the distinguishable fluorescent label does not comprise an intercalating dye that changes fluorescence after contacting DNA. 9. The method of claim 7 , wherein the distinguishable fluorescent label is covalently attached to the incorporable nucleotide by a linker at a position on the nitrogenous base. 10. The method of claim 1 , further comprising, after step (c), the steps of: (i) stripping the polymerase and the distinguishably labeled incorporable nucleotide of the second stabilized ternary complex from the blocked primed template nucleic acid molecule; (ii) cleaving a reversible terminator moiety from the blocked primed template nucleic acid molecule to create a deblocked primed template nucleic acid molecule comprising a 3′ terminus available for polymerization; and (iii) incorporating a reversible terminator into the deblocked primed template nucleic acid molecule. 11. The method of claim 1 , wherein the distinguishably labeled incorporable nucleotides in step (b) comprise at least two types of distinguishably labeled incorporable nucleotides, and wherein the detectable labels are different for each type of distinguishably labeled incorporable nucleotides. 12. The method of claim 1 , wherein the distinguishably labeled incorporable nucleotides in step (b) comprises at least three types of distinguishably labeled incorporable nucleotides, and wherein the detectable labels are different for each type of distinguishably labeled incorporable nucleotides. 13. The method of claim 1 , wherein the distinguishably labeled incorporable nucleotides in step (b) comprises four types of distinguishably labeled incorporable nucleotides, and wherein the detectable labels are different for each type of distinguishably labeled incorporable nucleotides. 14. The method of claim 1 , wherein none of the distinguishably labeled incorporable nucleotides of step (c) includes a reversible terminator moiety. 15. The method of claim 1 , wherein the reversible terminator nucleotide is unlabeled.

Assignees

Inventors

Classifications

  • involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

  • Subject matter not provided for in other groups of this subclass · CPC title

  • with ribosyl as saccharide radical · CPC title

  • Nucleotidyltransferases (2.7.7) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12344890B2 cover?
Method and composition for identifying cognate nucleotides in a Sequencing By Binding™ procedure, wherein one or more labeled nucleotides are detected in ternary complexes but never incorporated. Labeled nucleotides can be incorporable nucleotides that contact preformed blocked primed template nucleic acids. Alternatively, labeled nucleotides are labeled non-incorporable nucleotides. Labeled nu…
Who is the assignee on this patent?
Omniome Inc, Pacific Biosciences California Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).